What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Steven M. Dubinett spends much of his time researching Immunology, Cancer research, Immune system, Lung cancer and Cytokine.
Steven M. Dubinett has included themes like Cancer and Lung in his Immunology study.
His Cancer research study combines topics from a wide range of disciplines, such as Autocrine signalling, Internal medicine, Signal transduction, Growth factor receptor and Interleukin 12.
His studies in Immune system integrate themes in fields like Prostaglandin E2, Cell, Receptor and Antigen.
The Lung cancer study combines topics in areas such as Angiogenesis, Carcinogenesis, Apoptosis, Sense and Adenocarcinoma.
His Cytokine research incorporates elements of Tumor necrosis factor alpha and Adoptive cell transfer.
His most cited work include:
- Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. (479 citations)
- Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells (478 citations)
- Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. (454 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Lung cancer, Immunology, Cancer and Internal medicine.
His study on Cancer research also encompasses disciplines like
- Carcinogenesis which intersects with area such as Lung,
- Cytokine, which have a strong connection to Lymphocyte.
The various areas that he examines in his Lung cancer study include Angiogenesis, Metastasis and Adenocarcinoma.
His study in Cancer is interdisciplinary in nature, drawing from both microRNA and Disease.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology.
His Immune system research is multidisciplinary, incorporating perspectives in Cytotoxic T cell, Myeloid-derived Suppressor Cell and Antigen.
He most often published in these fields:
- Cancer research (56.85%)
- Lung cancer (47.72%)
- Immunology (28.08%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (56.85%)
- Lung cancer (47.72%)
- Cancer (26.71%)
In recent papers he was focusing on the following fields of study:
Steven M. Dubinett focuses on Cancer research, Lung cancer, Cancer, Immune system and Immunotherapy.
His biological study focuses on Tumor microenvironment.
His biological study spans a wide range of topics, including T cell and Antigen-presenting cell.
Steven M. Dubinett has researched Lung cancer in several fields, including Inflammation, Tumor progression, Lung and Adenocarcinoma.
His Cancer study deals with Oncology intersecting with Cancer immunotherapy and Progression-free survival.
The study incorporates disciplines such as Immunofluorescence, Cell cycle, Myeloid-derived Suppressor Cell and Antigen in addition to Immune system.
Between 2017 and 2021, his most popular works were:
- The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC) (66 citations)
- The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma (65 citations)
- In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer (55 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His main research concerns Cancer research, Lung cancer, Lung, Cancer and Carcinogenesis.
His Cancer research research includes elements of Cell, Inflammation, Immune system, Gene silencing and Epigenetics.
His Inflammation research integrates issues from Interleukin, Cytokine and Angiogenesis.
The concepts of his Lung cancer study are interwoven with issues in Tumor microenvironment, Carcinoma and Adenocarcinoma.
His Cancer research is multidisciplinary, relying on both Preclinical imaging, Oxidative phosphorylation, Membrane potential and Cell growth.
His studies deal with areas such as Immunohistochemistry, Positron emission tomography, Targeted therapy and Survival analysis as well as Carcinogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
